Hospice Care in Oklahoma - Ratings, Address, Contact

124 Hospice found. Showing 121 - 124

Compassus - Vinita Medicare Approved Location: 35904 South Highway 82, Vinita, Oklahoma 74301 Phone: (918) 891-2278

Heaven And Earth Hospice, Llc Medicare Approved Location: 410 East Illinois, Vinita, Oklahoma 74301 Phone: (918) 323-0100

First Choice Hospice, Llc Medicare Approved Location: 1002 South Mcquame Ave, Suite B, Wagoner, Oklahoma 74467 Phone: (918) 485-0079

Faith Hospice Of Southern Oklahoma, Llc Medicare Approved Location: 1611 Main Street, Suite 204, Woodward, Oklahoma 73801 Phone: (580) 254-2258

News Archive

Teva granted certiorari petition related to Mylan's ANDA for Copaxone

Mylan Inc. announced that today the Supreme Court of the United States granted certiorari in Mylan's patent litigation against Teva relating to Mylan's Abbreviated New Drug Application (ANDA) for glatiramer acetate (Copaxone).

Scientists identify unusual mutations in endometriosis using gene sequencing tools

Using gene sequencing tools, scientists from Johns Hopkins Medicine and the University of British Columbia have found a set of genetic mutations in samples from 24 women with benign endometriosis, a painful disorder marked by the growth of uterine tissue outside of the womb.

SensAble Technologies announces Release 3 of Dental Lab System

SensAble Technologies, Inc®, a leading provider of touch-enabled 3D modeling systems, dental CAD/CAM solutions and haptic devices, has announced Release 3 of the SensAble Dental Lab System (SDLS), with significant enhancements to this integrated system for creating dental restorations efficiently and more cost-effectively.

Benitec strengthens patent position in RNAi

Benitec Limited (ASX: BLT), (PINK:BNIKF), a world leader in expressed gene silencing for human therapeutics, is pleased to announce that the United States Patent and Trademark Office (USPTO) has today indicated that it is issuing the Re-examination Certificate, the formal final step in the USPTO's confirmation of patentability of claims in the key ‘099 Graham Patent [US Patent No. 6,573,099] "Genetic Constructs for Delaying or Repressing the Expression of a Target Gene", the wide-ranging platform technology patent covering the use of expressed RNA interference (RNAi) in human therapeutic applications.

Read more Medical News

› Verified 1 days ago

• 1
• 2
• 3
• 4
• 5
• 6
• 7(current)